Johnson & Johnson Innovation (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Its portfolio companies benefit from the full global capabilities of Johnson & Johnson as JJDC collaborates to drive innovation. JJDC finds transformative ideas and helps them mature into real solutions for todays patients. Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations. JJDC invests across sectorspharmaceuticals, medical devices, and consumer healthcareand at all stages, from seed-level startups to Series B and beyond. JJDC also makes private investments in public equity. All of its portfolio companies receive the same unwavering commitment. JJDC takes a long-term approach, deploying the full capabilities of the Johnson & Johnson family of companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization. JJDC's team includes leaders in the healthcare and technology communities, many with deep R&D experience.